{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:34:07Z","timestamp":1788950047282,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and technology projects of Shenyang","award":["23-506-3-01-25"],"award-info":[{"award-number":["23-506-3-01-25"]}]},{"name":"Science and Technology Program of Shenyang city","award":["22-321-33-47"],"award-info":[{"award-number":["22-321-33-47"]}]},{"name":"General Program of Natural Science Foundation of Liaoning Province","award":["2021-MS-196"],"award-info":[{"award-number":["2021-MS-196"]}]},{"name":"Liaoning Provincial Natural Science Foundation Program","award":["2023-MS-051"],"award-info":[{"award-number":["2023-MS-051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1245\/s10434-024-16429-9","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T19:02:50Z","timestamp":1730142170000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nomogram for the Pathological Complete Response After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4835-6140","authenticated-orcid":false,"given":"Liping","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengri","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5804-2017","authenticated-orcid":false,"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7391-3318","authenticated-orcid":false,"given":"Shuang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"3","key":"16429_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"16429_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"16429_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106\u201319.","journal-title":"Eur Urol."},{"issue":"6","key":"16429_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016;21(6):708\u201315.","journal-title":"Oncologist."},{"issue":"12","key":"16429_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/PAS.0000000000001371","volume":"43","author":"CS Voskuilen","year":"2019","unstructured":"Voskuilen CS, Oo HZ, Genitsch V, Smit LA, Vidal A, Seiler R. Multicenter validation of histopathologic tumor regression grade after neoadjuvant chemotherapy in muscle-invasive bladder carcinoma. Am J Surg Pathol. 2019;43(12):1600\u201310.","journal-title":"Am J Surg Pathol."},{"issue":"9","key":"16429_CR6","doi-asserted-by":"publisher","first-page":"572.e21","DOI":"10.1016\/j.urolonc.2019.04.027","volume":"37","author":"N Waingankar","year":"2019","unstructured":"Waingankar N, Jia R, Marqueen KE, et al. The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer. Urol Oncol. 2019;37(9):572.e21-572.e28.","journal-title":"Urol Oncol."},{"issue":"5","key":"16429_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin."},{"key":"16429_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","volume":"2","author":"L Boeri","year":"2019","unstructured":"Boeri L, Soligo M, Frank I, et al. Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes. Eur Urol Oncol. 2019;2:390.","journal-title":"Eur Urol Oncol."},{"issue":"1","key":"16429_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clgc.2015.08.006","volume":"14","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari K, Sverrisson EF, Sharma P, et al. Clinical outcomes after neoadjuvant chemotherapy and radical cystectomy in the presence of urothelial carcinoma of the bladder with squamous or glandular differentiation. Clin Genitourin Cancer. 2016;14(1):82\u20138.","journal-title":"Clin Genitourin Cancer."},{"issue":"1","key":"16429_CR10","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.clgc.2015.09.013","volume":"14","author":"VK Pokuri","year":"2016","unstructured":"Pokuri VK, Syed JR, Yang Z, et al. Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma. Clin Genitourin Cancer. 2016;14(1):e59-65.","journal-title":"Clin Genitourin Cancer."},{"key":"16429_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.euros.2022.05.001","volume":"41","author":"D D'Andrea","year":"2022","unstructured":"D\u2019Andrea D, Shariat SF, Soria F, et al. The impact of primary versus secondary muscle-invasive bladder cancer at diagnosis on the response to neoadjuvant chemotherapy. Eur Urol Open Sci. 2022;41:74\u201380.","journal-title":"Eur Urol Open Sci."},{"issue":"5","key":"16429_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis."},{"issue":"2","key":"16429_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00345-013-1128-x","volume":"32","author":"PH Kim","year":"2014","unstructured":"Kim PH, Kent M, Zhao P, et al. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2014;32(2):453\u20139.","journal-title":"World J Urol."},{"key":"16429_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11255-016-1491-9","volume":"49","author":"W Otto","year":"2017","unstructured":"Otto W, Breyer J, Herdegen S, et al. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach. Int Urol Nephrol. 2017;49:431.","journal-title":"Int Urol Nephrol."},{"key":"16429_CR15","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:7594.","journal-title":"BMJ."},{"key":"16429_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/cncr.24052","volume":"115","author":"JL Gore","year":"2009","unstructured":"Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End ResultseMedicare analysis. Cancer. 2009;115:988\u201396.","journal-title":"Cancer."},{"issue":"2","key":"16429_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2018.09.002","volume":"75","author":"EJ Pietzak","year":"2019","unstructured":"Pietzak EJ, Zabor EC, Bagrodia A, et al. Genomic differences between \u201cprimary\u201d and \u201csecondary\u201d muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy. Eur Urol. 2019;75(2):231\u20139.","journal-title":"Eur Urol."},{"key":"16429_CR18","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","volume":"31","author":"N Lagwinski","year":"2007","unstructured":"Lagwinski N, Thomas A, Stephenson AJ, et al. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol. 2007;31:1777\u201387.","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"16429_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/BLC-200303","volume":"6","author":"JL Pfail","year":"2020","unstructured":"Pfail JL, Audenet F, Martini A, et al. Survival of patients with muscle-invasive urothelial cancer of the bladder with residual disease at time of cystectomy: a comparative survival analysis of treatment modalities in the National Cancer Database. Bladder Cancer. 2020;6(3):265\u201376.","journal-title":"Bladder Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16429-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:07:32Z","timestamp":1734631652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16429-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["16429"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16429-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the author's have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Ethical approval (2023PS705K) was provided by the Ethics Committee of Shengjing Hospital Affiliated China Medical University. Informed consent from all eligible patients was obtained. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}